BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 29112013)

  • 21. Lymphoproliferative disorders in autoimmune diseases in Japan: analysis of clinicopathological features and Epstein-Barr virus infection.
    Hoshida Y; Tomita Y; Zhiming D; Yamauchi A; Nakatsuka S; Kurasono Y; Arima Y; Tsudo M; Shintaku M; Aozasa K
    Int J Cancer; 2004 Jan; 108(3):443-9. PubMed ID: 14648712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
    Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
    Takahashi E; Ohshima K; Kimura H; Hara K; Suzuki R; Kawa K; Eimoto T; Nakamura S;
    Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication.
    Hoshida Y; Xu JX; Fujita S; Nakamichi I; Ikeda J; Tomita Y; Nakatsuka S; Tamaru J; Iizuka A; Takeuchi T; Aozasa K
    J Rheumatol; 2007 Feb; 34(2):322-31. PubMed ID: 17117491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
    Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
    Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occurrence of Epstein-Barr virus-associated plasmacytic lymphoproliferative disorder after antithymocyte globulin therapy for aplastic anemia: a case report with review of the literature.
    Nakanishi R; Ishida M; Hodohara K; Okuno H; Yoshii M; Horinouchi A; Shirakawa A; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H
    Int J Clin Exp Pathol; 2014; 7(4):1748-54. PubMed ID: 24817974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus-associated B cell lymphoproliferative disorder following mismatched related T cell-depleted bone marrow transplantation.
    Chiang KY; Hazlett LJ; Godder KT; Abhyankar SH; Christiansen NP; van Rhee F; Lee CG; Bridges K; Parrish RS; Henslee-Downey PJ
    Bone Marrow Transplant; 2001 Dec; 28(12):1117-23. PubMed ID: 11803352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunodeficiency-Associated Lymphoproliferative Disorders.
    Zeppa P; Cozzolino I
    Monogr Clin Cytol; 2018; 23():77-80. PubMed ID: 29131000
    [No Abstract]   [Full Text] [Related]  

  • 29. New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders.
    Quintanilla-Martinez L; Swerdlow SH; Tousseyn T; Barrionuevo C; Nakamura S; Jaffe ES
    Virchows Arch; 2023 Jan; 482(1):227-244. PubMed ID: 36216980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A look into the evolution of Epstein-Barr virus-induced lymphoproliferative disorders: a case study.
    Ambrosio MR; Rocca BJ; Ginori A; Mourmouras V; Amato T; Vindigni C; Lazzi S; Leoncini L
    Am J Clin Pathol; 2015 Nov; 144(5):817-22. PubMed ID: 26486748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr Virus-Associated Nodal Marginal Zone Lymphoma: Part of the Spectrum of Posttransplant Lymphoproliferative Disorder?
    Cheung CY; Lau WH; Cheuk W
    Int J Surg Pathol; 2019 Feb; 27(1):94-97. PubMed ID: 29944019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphoproliferative disorders in immunocompromised individuals and therapeutic antibodies for treatment.
    Yang X; Miyawaki T; Kanegane H
    Immunotherapy; 2013 Apr; 5(4):415-25. PubMed ID: 23557424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunodeficiency-associated lymphoid proliferations (ALPS, HIV, and KSHV/HHV8).
    Chadburn A
    Semin Diagn Pathol; 2013 May; 30(2):113-29. PubMed ID: 23537912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus-positive cytotoxic T-cell lymphoma followed by chronic active Epstein-Barr virus infection-associated T/NK-cell lymphoproliferative disorder: a case report.
    Kato S; Miyata T; Takata K; Shimada S; Ito Y; Tomita A; Elsayed AA; Takahashi E; Asano N; Kinoshita T; Kimura H; Nakamura S
    Hum Pathol; 2013 Dec; 44(12):2849-52. PubMed ID: 24012167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphopenia at diagnosis predicts survival of patients with immunodeficiency-associated lymphoproliferative disorders.
    Watanabe M; Kanda J; Hishizawa M; Nishikori M; Kondo T; Yamashita K; Takaori-Kondo A
    Ann Hematol; 2020 Jul; 99(7):1565-1573. PubMed ID: 32436013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders.
    Park S; Ko YH
    J Dermatol; 2014 Jan; 41(1):29-39. PubMed ID: 24438142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunodeficiency-Associated Epstein-Barr Virus-Positive B-cell Lymphoproliferative Disorders: A Review and New Paradigm.
    Chapman J
    Surg Pathol Clin; 2023 Jun; 16(2):213-231. PubMed ID: 37149357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-transplantation lymphoproliferative disorders in Mexico: an aggressive clonal disease associated with Epstein-Barr virus type A.
    Quintanilla-Martínez L; Lome-Maldonado C; Schwarzmann F; Gredler E; Reyes E; Angeles-Angeles A; Fend F
    Mod Pathol; 1998 Feb; 11(2):200-8. PubMed ID: 9504692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
    Akar Özkan E; Özdemir BH; Deniz EE; Tunca MZ; Haberal M
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.